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Increased levels of transition metals like Fe, Ni, Cr, Hg
and Pb are related to free radical generation, lipid
peroxidation, DNA strand breaks and tumor growth in
cellular systems. In order to evaluate the correlation to
malignant growth in humans we investigated the accu-
mulation of heavy metals in 8 healthy and 20 breast
cancer biopsies by means of a standardized AAS metho-
dology. A highly significant concentration of Fe, Ni, Cr,
Zn, Cd, Hg and Pb was recorded in the cancer samples
when compared with the control group (p ≤ 0.001). As
previously reported by us, the high heavy metal levels
found in various tumors may be used for therapeutic
interventions with ascorbic acid or substituted phenolic
mixtures. The autooxidation of vitamin C in the pre-
sence of heavy metals strongly increase superoxide and
H2O2 concentrations at the tumor site with oxidosis
and apoptosis induction.
In turn, bioactivation of phenolic compounds in the
presence of heavy metals and an overexpressed NADPH-
quinone oxidoreductase leads to a significant generation
of superoxide and semiquinone radicals with deleterious
effects for the metal rich malignant cells. Thus, the accu-
mulation of transition metals in malignant tissue confers
both ascorbate and phenolic compounds an increased
tumor selectivity.
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